IL15 and cancer: Many of the immune regulatory axes can be targeted in both autoimmune diseases and cancer, usually in an opposite manner—targeting different cytokines (including IL-2, IL-6, IL-10, IL-15, IL-17, and TNF-α) to manipulate the tolerance and increasing or decreasing the regulatory populations of the cells.